Compound information
- Natural Products
- ZC1727256
- Molecular Formula
- C17H17NO4
- Molecular Weight
- 299.115758024 g/mol
- Structure
-
- IUPAC Name
- 4-[(1S)-1-(benzyloxycarbonylamino)ethyl]benzoic acid
- InChI
- InChI=1S/C17H17NO4/c1-12(14-7-9-15(10-8-14)16(19)20)18-17(21)22-11-13-5-3-2-4-6-13/h2-10,12H,11H2,1H3,(H,18,21)(H,19,20)/t12-/m0/s1
- InChI Key
- XZHNWUGYLBANCU-LBPRGKRZSA-N
- SMILES
- C[C@H](NC(=O)OCc1ccccc1)c1ccc(C(=O)O)cc1
- Source
- ZINC000095080275
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 22 | Ring Count | 2 |
Heteroatom Count | 5 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 75.63 Å2 | LogP | 3.223 |
LogS | -3.578 | LogD | 2.595 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.001 | Pgp substrate | 0.086 |
HIA | 0.967 | F20 % | 0.994 |
F30 % | 0.956 | Caco-2 | -4.952 |
MDCK | -5.204 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.17 | PPB | 93.375 |
VD | 0.221 | Fu | 1.175 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.054 | CYP1A2 substrate | 0.773 |
CYP2A6 substrate | 0.675 | CYP2B6 substrate | 0.657 |
CYP2C19 inhibitor | 0.162 | CYP2C19 substrate | 0.91 |
CYP2C8 substrate | 0.779 | CYP2C9 inhibitor | 0.076 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.096 |
CYP2D6 substrate | 0.849 | CYP2E1 substrate | 0.161 |
CYP3A4 inhibitor | 0.049 | CYP3A4 substrate | 0.97 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.83 | CL | 1.377 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.004 | Hepatotoxicity | 0.626 |
Mutagenicity | 0.004 | Rat Oral Acute Toxicity | 0.107 |
FDAMDD | 0.063 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.038 | Eye Corrosion | 0.003 |
Eye Irritation | 0.014 | Respiratory Toxicity | 0.004 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.447 | IGC50 | 2.461 |
LC50FM | 3.658 | LC50DM | 4.809 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.193 | NR-AR-LBD | 0.209 |
NR-AhR | 0.009 | NR-Aromatase | 0.042 |
NR-ER | 0.285 | NR-ER-LBD | 0.292 |
NR-PPAR-gamma | 0.483 | SR-ARE | 0.038 |
SR-ATAD5 | 0.384 | SR-HSE | 0.103 |
SR-MMP | 0.009 | SR-p53 | 0.015 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.